|
Introduction (12)
|
|
Editorial (0)
|
|
Perspective (1)
|
|
Point-Counterpoint (0)
|
|
Cellular Pathobiology (96)
|
|
Cellular Pathobiology: Cancer Genes and Genomics (34)
|
|
Cellular Pathobiology: Proliferation, Senescence, and Death (52)
|
|
Cellular Pathobiology: Metabolism and Physiology (14)
|
|
Cellular Pathobiology: DNA Damage and Stress Responses (20)
|
|
Tumor Biology (71)
|
|
Tumor Biology: Angiogenesis (11)
|
|
Tumor Biology: Invasion and Metastasis (34)
|
|
Tumor Biology: Inflammation and Immune Escape (25)
|
|
Tumor Biology: Model Organisms and Imaging (16)
|
|
Therapeutics and Targets (121)
|
|
Therapeutics and Targets: Identification, Validation, and Markers (66)
|
|
Therapeutics and Targets: Experimental Therapeutics– Small Molecules (27)
|
|
Therapeutics and Targets: Experimental Therapeutics– Biologics (15)
|
|
Therapeutics and Targets: Drug Mechanisms and Resistance (29)
|
|
Therapeutics and Targets: Pharmacology and Toxicology (10)
|
|
Epidemiology and Prevention (59)
|
|
Epidemiology and Prevention: Genetics and Biomarkers (34)
|
|
Epidemiology and Prevention: Nutrition (4)
|
|
Epidemiology and Prevention: Chemoprevention (13)
|
|
Epidemiology and Prevention: Screening, Behavior, and Survivorship (13)
|
|
Cancer Immunology (25)
|
|
Cancer Immunology: Innate Immunity (7)
|
|
Cancer Immunology: Adaptive Immunity (13)
|
|
Cancer Immunology: Antibodies (4)
|
|
Cancer Immunology: Immunotherapy (18)
|
|
Clinical Research (49)
|
|
Clinical Research: Clinical Pharmacology (5)
|
|
Clinical Research: Clinical Trials (23)
|
|
Clinical Research: Response Markers and Mechanisms (13)
|
|
Clinical Research: Imaging, Diagnosis, and Prognosis (23)
|
|
Special Article (0)
|
|
Editorial (0)
|
|
Introduction (0)
|
|
Commentary (0)
|
|
Review (0)
|
|
Perspective (0)
|
|
Point-Counterpoint (0)
|
|
Meeting Report (0)
|
|
Oncogenesis (0)
|
|
Oncogenesis: Biomarkers (0)
|
|
Oncogenesis: In Vitro (0)
|
|
Oncogenesis: Animal Models (0)
|
|
Oncogenesis: Clinical Models (0)
|
|
Oncogenesis: Intraepithelial Neoplasia/Premalignancy (0)
|
|
Epidemiology (0)
|
|
Epidemiology: Biomarkers (0)
|
|
Epidemiology: Molecular Epidemiology (0)
|
|
Epidemiology: Classical Epidemiology (0)
|
|
Epidemiology: Nutritional Epidemiology (0)
|
|
Epidemiology: Environmental Toxicology (0)
|
|
Risk Assessment (0)
|
|
Risk Assessment: Biomarkers (0)
|
|
Risk Assessment: Hereditary Cancer Syndromes/Cancer Genetics (0)
|
|
Risk Assessment: Risk Modeling and Prediction (0)
|
|
Risk Assessment: Biostatistics/Bioinformatics (0)
|
|
Early Detection (0)
|
|
Early Detection: Biomarkers: Discovery, Methodology, Validation (0)
|
|
Early Detection: Imaging (0)
|
|
Early Detection: Biostatistics/Bioinformatics (0)
|
|
Clinical Intervention (0)
|
|
Clinical Intervention:Molecular Targeted Drugs (0)
|
|
Clinical Intervention: Diet and Diet-related Factors (0)
|
|
Clinical Intervention: Surgery (0)
|
|
Clinical Intervention: Biomarkers (0)
|
|
Clinical Intervention: Early-Phase (I/II) Clinical or Translational Trials (0)
|
|
Clinical Intervention: Definitive (Phase III) Clinical or Translational Trials (0)
|
|
Clinical Intervention: Intraepithelial Neoplasia/Premalignancy (0)
|
|
Clinical Intervention: Pharmacogenomics (0)
|
|
Clinical Intervention: Biostatistics/Bioinformatics (0)
|
|
Clinical Intervention: Health Policy (0)
|
|
Preclinical Intervention (0)
|
|
Preclinical Intervention: In Vitro: Drugs, Mechanisms (0)
|
|
Preclinical Intervention: In Vivo (Animals): Drugs, Nutritional Interventions, Mechanisms (0)
|
|
Preclinical Intervention: Biomarkers (0)
|
|
Preclinical Intervention: Intraepithelial Neoplasia/Premalignancy (0)
|
|
Preclinical Intervention: Biostatistics/Bioinformatics (0)
|
|
Behavioral Science (0)
|
|
Behavioral Science: Interventions: Behavioral, Pharmacologic, Pharmacogenetic (0)
|
|
Behavioral Science: Health Services and Outcomes Research (0)
|
|
Behavioral Science: Survivorship/Psychosocial Oncology (0)
|
|
Behavioral Science: Health Communications (0)
|
|
Behavioral Science: Health Policy (0)
|
|
Behavioral Science: Education (0)
|
